Clinical Pfizer Trials

While Pfizer in July released partial data on the outcomes from the six-month assessment ending March 13th, the new FDA report includes more comprehensive data, and shows a significantly higher number of all-cause fatalities among the vaccinated cohort. The Pfizer report in late July of this year showed effectively equal all-cause fatality rates between the vaccine and placebo cohorts six months after the tests were conducted, 15 deaths among the nearly 22,000 vaccine recipients, versus 14 deaths among the nearly 22,000 placebo recipients.

The FDA report, however, revealed a larger number of deaths by all causes in both groups, with 17 deaths among the control group and 21 in the vaccinated cohort. The relative difference in all-cause deaths between the two cohorts amounts to 23.5%, though the absolute number of deaths was small – 38 total for all participants in the trial.

Read more at “FDA Report Shows That 6 Months After Receiving COVID Vaccinations, The Death Rate Is 24% Higher Among The Vaccinated Than The Unvaccinated.”